Hormone replacement therapy in Germany: Determinants and possible health-related outcomes: Results of National Health Surveys from 1984 to 1999

Maturitas

Volumn 52, Issue 3-4, 2005, Pages 223-234

  Du, Yong ^a,c   Melchert, Hans Ulrich ^a   Schäfer Korting, Monika ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c FUDAN UNIVERSITY   (China)

Author keywords

Conjugated equine estrogens; Coronary heart disease; Germany; Hormone replacement therapy; National Health Surveys

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; LIPID;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HEALTH; HEALTH STATUS; HEALTH SURVEY; HEART PROTECTION; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; OBSERVATION; PATIENT SATISFACTION; POPULATION; REGRESSION ANALYSIS; SOCIOECONOMICS; TREATMENT OUTCOME;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; GERMANY; HEALTH STATUS; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE STYLE; LIPIDS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; SMOKING; SOCIAL CLASS; TREATMENT OUTCOME;

EQUIDAE;

EID: 27644559584     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.01.014     Document Type: Article

References (47)

1. V. Beral, E. Banks, G. Reeves, and P. Appleby Use of HRT and the subsequent risk of cancer J Epidemiol Biostat 4 1999 191 215
2. N.L. Keating, P.D. Cleary, A.S. Rossi, A.M. Zaslavsky, and J.Z. Ayanian Use of hormone replacement therapy by postmenopausal women in the United States Ann Intern Med 130 1999 545 553
3. F. Grodstein, J.E. Manson, G.A. Colditz, W.C. Willett, F.E. Speizer, and M.J. Stampfer A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease Ann Intern Med 133 2000 933 941
4. F. Grodstein, J.E. Manson, and M.J. Stampfer Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study Ann Intern Med 135 2001 1 8
5. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
6. J.E. Manson, J. Hsia, and K. Johnson Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
7. S. Wassertheil-Smoller, S.L. Hendrix, and M. Limacher Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: A randomized trial JAMA 289 2003 2673 2684
8. R.T. Chlebowski, S.L. Hendrix, and R.D. Langer Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial JAMA 289 2003 3243 3253
9. R.T. Chlebowski, J. Wactawski-Wende, and C. Ritenbaugh Estrogen plus progestin and colorectal cancer in postmenopausal women N Engl J Med. 350 2004 991 1004
10. S.A. Shumaker, C. Legault, and S.R. Rapp Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: A randomized controlled trial JAMA 289 2003 2651 2662
11. S.R. Rapp, M.A. Espeland, and S.A. Shumaker Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 2003 2663 2672
12. J. Hays, J.K. Ockene, and R.L. Brunner Effects of estrogen plus progestin on health-related quality of life N Engl J Med 348 2003 1839 1854
13. D. Grady, D. Herrington, and V. Bittner Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
14. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
15. H.N. Hodis, W.J. Mack, and S.P. Azen Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women N Engl J Med 349 2003 535 545
16. V. Beral Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
17. J.E. Mueller, A. Döring, M. Heier, and H. Löwel Prevalence and determinants of hormone replacement therapy in German women 1984-1995 Maturitas 43 2002 95 104
18. GCP Study Group The German Cardiovascular Prevention Study (GCP): design and methods GCP Study Group Eur Heart J 9 1988 1058 1066
19. H.U. Melchert, B. Görsch, and H. Hoffmeister Nichtstationäre Arzneimittelanwendung und subjektive Arzneimittelverträglichkeit in der bundesdeutschen Wohnbevölkerung der 25- bis 69jährigen: zur Epidemiologie des Arzneimittelkonsums und der unerwünschten Arzneimittelwirkungen; Ergebnisse der Erhebung des ersten Nationalen Untersuchungs-Surveys 1984-1986. RKI-Schriften; 1995 1st ed. 1995 MMV Medizin Verlag München ISBN 3-8208-1274-1
20. H. Knopf, and H.U. Melchert Bundes-Gesundheitssurvey: Arzneimittelgebrauch 2003 Robert Koch-Institut Berlin ISBN 3-89606-147-x
21. B.J. Oddens, and M.J. Boulet Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance Obstet Gynecol 90 1997 269 277
22. V. Ringa, B. Ledesert, R. Gueguen, F. Schiele, and G. Breart Determinants of hormonal replacement therapy in recently postmenopausal women Eur J Obstet Gynecol Reprod Biol 45 1992 193 200
23. P. Topo, T. Klaukka, E. Hemminki, and A. Uutela Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women J Epidemiol Community Health 45 1991 277 280
24. J. Townsend Hormone replacement therapy: assessment of present use, costs, and trends Br J Gen Pract 48 1998 955 958
25. C. Li, G. Samsioe, J. Lidfelt, C. Nerbrand, and C.D. Agardh Important factors for use of hormone replacement therapy: A population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study Menopause 7 2000 273 281
26. K. Bakken, A.E. Eggen, and E. Lund Hormone replacement therapy in Norwegian women, 1996-1997 Maturitas 40 2001 131 141
27. D. Friedman-Koss, C.J. Crespo, M.F. Bellantoni, and R.E. Andersen The relationship of race/ethnicity and social class to hormone replacement therapy: Results from the Third National Health and Nutrition Examination Survey 1988-1994 Menopause 9 2002 264 272
28. S. Shah, T.J. Harris, and D.G. Cook Differences in hormone replacement therapy use by social class, region and psychological symptoms BJOG 108 2001 269 275
29. H. Hoffmeister, H. Hüttner, H. Stolzenberg, H. Lopez, and J. Winkler Sozialer Status und Gesundheit: Nationaler Gesundheits-Surveys 1984-1986. BGA-Schriften 2/92 ed. 1992 MMV Medizin Verlag München
30. N.F. Marks, and D.S. Shinberg Socioeconomic status differences in hormone therapy Am J Epidemiol 148 1998 581 593
31. D.H. Wilson, A.W. Taylor, and A.H. MacLennan Health status of hormone replacement therapy users and non-users as determined by the SF-36 quality-of-life dimension Climacteric 1 1998 50 54
32. S.C. Clarke, J. Kelleher, H. Lloyd-Jones, M. Slack, and P.M. Schofiel A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study BJOG 109 2002 1056 1062
33. C.M. Viscoli, L.M. Brass, W.N. Kernan, P.M. Sarrel, S. Suissa, and R.I. Horwitz A clinical trial of estrogen-replacement therapy after ischemic stroke N Engl J Med 345 2001 1243 1249
34. D.M. Herrington, D.M. Reboussin, and K.B. Brosnihan Effects of estrogen replacement on the progression of coronary-artery atherosclerosis N Engl J Med 343 2000 522 529
35. A.M. Kanaya, D. Herrington, and E. Vittinghoff Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial Ann Intern Med 138 2003 1 9
36. K.L. Margolis, D.E. Bonds, and R.J. Rodabough Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial Diabetologia 47 2004 1175 1187
37. C.J. Crespo, E. Smit, A. Snelling, C.T. Sempos, and R.E. Andersen NHANES III. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III) Diabetes Care 25 2002 1675 1680
38. M. Hemelaar, M.J. van der Mooren, and V. Mijatovic Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study Menopause 10 2003 550 558
39. M.G. Shlipak, J.A. Simon, and E. Vittinghoff Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause JAMA 283 2000 1845 1852
40. I.F. Godsland Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 to 2000 Fertil Steril 75 2001 898 915
41. L.H. Kuller Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative Arterioscler Thromb Vasc Biol 23 2003 11 16
42. J.C. Stevenson, D. Crook, and I.F. Godsland Influence of age and menopause on serum lipids and lipoproteins in healthy women Atherosclerosis 98 1993 83 90
43. A.O. Mueck, and H. Seeger Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women Maturitas 49 2004 189 203
44. G. Mercuro, S. Zoncu, and D. Piano Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension Am J Hypertens 11 1998 909 913
45. B. Cacciatore, I. Paakkari, and R. Hasselblatt Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24 h ambulatory blood pressure in postmenopausal women Am J Obstet Gynecol 184 2001 904 909
46. M.B. Sorensen, V. Rasmussen, G. Jensen, and B. Ottesen Temporal changes in clinic and ambulatory blood pressure during cyclic post-menopausal hormone replacement therapy J Hypertens 18 2001 1387 1391
47. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 1997 1047 1059